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Cross-feeding based on the metabolite 1,2-propanediol has been proposed to 21 
have an important role in the establishment of trophic interactions among gut symbionts, 22 
but its ecological importance has not been empirically established. Here, we show that 23 
in vitro growth of Lactobacillus reuteri ATCC PTA 6475 is enhanced through 1,2-24 
propanediol produced by Bifidobacterium breve UCC2003 and Escherichia coli MG1655 25 
from the metabolization of fucose and rhamnose, respectively. Work with isogenic 26 
mutants showed that the tropic interaction is dependent on the pduCDE operon in L. 27 
reuteri, which encodes for the ability to use 1,2-propanediol, and the L-fucose permease 28 
(fucP) gene in B. breve, which is required for 1,2-propanediol formation from fucose. 29 
Experiments in gnotobiotic mice revealed that, although the pduCDE operon bestows a 30 
fitness burden on L. reuteri ATCC PTA 6475 in the mouse digestive tract, the ecological 31 
performance of the strain was enhanced in the presence of B. breve UCC2003 and the 32 
mucus-degrading species Bifidobacterium bifidum. The use of the respective pduCDE 33 
and fucP mutants of L. reuteri and B. breve in the mouse experiments indicated that the 34 
trophic interaction was specifically based on 1,2-propanediol. Overall, our work 35 
established the ecological importance of cross-feeding relationships based on 1,2-36 























Importance  40 
Through experiments in gnotobiotic mice that employed isogenic mutants of 41 
bacterial strains that produce (Bifidobacterium breve) and utilize (Lactobacillus reuteri) 42 
1,2-propanediol, this study provides mechanistic insight into the ecological ramifications 43 
of a trophic interaction between gut symbionts. The findings improve our understanding 44 
on how cross-feeding influences the competitive fitness of L. reuteri in the vertebrate gut 45 
and revealed a putative selective force that shaped the evolution of the species. The 46 
findings are relevant as they provide a basis to design rational microbial-based 47 
strategies to modulate gut ecosystems, which could employ mixtures of bacterial strains 48 
that establish trophic interactions or a personalized approach based on the ability of a 49 
resident microbiota to provide resources for the incoming microbe.  50 
  51 
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The gut microbiota is a complex microbial community whose members form 53 
interdependent trophic relationships that determine the ecology of bacterial populations 54 
and their interplay with the host (1). One such interaction involves the exchange of 55 
products between microbes, otherwise known as cross-feeding (2). Cross-feeding of 56 
nutrients is central to the fermentative degradation of non-digestible dietary fibres and 57 
host-derived substrates, such as mucin or human milk oligosaccharides (HMO) (3-10). 58 
For example, glycans released from the partial degradation of HMO are utilized by other 59 
bifidobacterial species (11), and certain bifidobacteria and Akkermansia muciniphila 60 
liberate glycans from host mucins that are utilized by other inhabitants of the gut (6, 12). 61 
Similarly, Ruminococcus bromii releases carbohydrates from resistant starch 62 
fermentations into the gut environment (13). These interactions ultimately lead to the 63 
formation of dynamic metabolic networks essential in the ecology of the gut microbiome 64 
and the production of short chain fatty acids (SCFA), which are a key ecosystem service 65 
that benefits the host (14, 15). 66 
Trophic interactions can also result from the exchange of metabolic end-products 67 
derived from fermentation processes. Hydrogenotrophic microbes utilize the molecular 68 
hydrogen produced by several fermentative organisms, a process important to maintain 69 
energy flux (16). In addition, cross-feeding based on intermediary metabolites such as 70 
lactate, acetate, succinate, and 1,2-propanediol is important for the production of SCFA 71 
(5). In the gut, 1,2-propanediol results from the microbial fermentation of deoxyhexose 72 
sugars that originate from the hydrolyzation of dietary fibre, fucosylated HMOs, and host 73 
mucins, such as rhamnose and fucose (17, 18). Several gut commensal bacteria (i.e. 74 
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Bacteroides thetaiotaomicron, Roseburia inulinivorans, Escherichia coli, and 75 
Bifidobacterium breve) can produce 1,2-propanediol from the fermentation of either 76 
rhamnose or fucose (3, 5, 17, 18). Other bacteria such as Eubacterium hallii and 77 
Lactobacillus reuteri do not utilize fucose or rhamnose directly but metabolize 1,2-78 
propanediol (19-21) and convert it to propanol and propionate (21, 22). Cross-feeding of 79 
1,2-propanediol between Eu. hallii and Bifidobacterium species based on metabolism of 80 
mucin and HMO has been studied in vitro (3, 4, 6). Although cross-feeding based on 81 
1,2-propanediol is considered important in gut ecosystems (5) and has been shown to 82 
confer a fitness advantage in vivo for pathogens such as Salmonella spp. (23), its 83 
ecological importance for bacterial gut symbionts, and the underlying mechanisms by 84 
which it impacts bacterial performance in the gut, have not been empirically established 85 
in vivo in a tractable experimental model.  86 
In both Eu. hallii and L. reuteri, 1,2-propanediol is metabolized through the 87 
cobalamin-dependent glycerol/diol dehydratase encoded in the pduCDE operon, found 88 
in the pdu-cbi-cob-hem gene (pdu) cluster (19-21). The glycerol/dehydratase converts 89 
1,2-propanediol to propionaldehyde and further to propanol and propionate and have 90 
been shown to increase growth rates for L. reuteri in vitro (19, 24). In L. reuteri, the pdu 91 
cluster is observed predominantly in two L. reuteri phylogenetic lineages that are 92 
dominated by strains from human, herbivore, and chicken origin, but rarer in strains 93 
from other hosts such as mice and rats (25). This distribution suggests that the cluster 94 
constitutes an adaptation to the characteristics of the gastrointestinal tract of specific 95 
hosts (26, 27). In the murine forestomach, which is densely colonized by L. reuteri (25), 96 
fermentable mono- and disaccharides are in ample supply (28). In contrast, distal 97 
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portions of the human intestinal tract are characterized by low concentrations of mono- 98 
and disaccharides. The pdu cluster may therefore constitute a colonization factor in the 99 
distal regions of the gut, to take advantage of 1,2-propanediol produced by other 100 
microbes (19, 25).  101 
Most studies on diol-metabolism in L. reuteri have focused on the synthesis of the 102 
antimicrobial intermediate β-hydroxypropionaldehyde (reuterin) from glycerol, which is 103 
also mediated by the pdu operon (29). It remains unclear whether L. reuteri uses the 104 
pdu operon to engage in cross-feeding interrelationships with other gut bacterial species 105 
that produce 1,2-propanediol in its gastrointestinal habitat, and how this interaction 106 
contributes to its ecological competitiveness. It was therefore the aim of this study to 107 
characterize the ecological importance of 1,2-propanediol-cross-feeding between L. 108 
reuteri and the 1,2-propanediol producers Bifidobacterium breve and Escherichia coli, 109 
both in vitro and in the digestive tract of mice. 110 
 111 
Results  112 
1,2-propanediol enhances growth of L. reuteri in vitro  113 
We first sought to confirm the importance of 1,2-propanediol metabolism for L. 114 
reuteri L. reuteri ATCC PTA 6475 (referred to as L. reuteri PTA 6475) growth in vitro. 115 
The presence of 1,2-propanediol in the medium containing glucose improved growth 116 
rates and increased the final cell density of the strain when compared to the growth 117 
solely on glucose or to growth of a pduCDE delection mutant (referred to as L. reuteri 118 
ΔpduCDE) (Fig. 1A). Neither L. reuteri PTA 6475 nor L. reuteri ΔpduCDE were able to 119 
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use 1,2-propanediol as the sole carbon source for growth (Fig. 1A). To confirm that the 120 
enhanced growth of L. reuteri PTA 6475 was due to 1,2-propanediol metabolism, the 121 
metabolic end-products in the supernatant were measured using HPLC. As shown in 122 
Figure 1B and C, L. reuteri PTA 6475 but not L. reuteri ΔpduCDE converted 1,2-123 
propanediol to propanol and low concentrations of propionate. For L. reuteri PTA 6475 124 
but not L. reuteri ΔpduCDE, utilization of 1,2-propanediol resulted in acetate production 125 
and decreased production of ethanol (Fig. 1D & E; Fig. S1A & B). These findings 126 
confirm that L. reuteri PTA 6475 is able to disproportionate 1,2-propanediol to propanol 127 
and propionate (22). However, 1,2-propanediol is not used as sole substrate but co-128 
metabolized with glucose. Predominant production of propanol demonstrates that the 129 
reducing branch of the propanediol pathway is preferred over the oxidizing branch to 130 
regenerate electron acceptors, thus enhancing acetate formation and ATP production, 131 
and therefore growth (30). 132 
Interspecies cross-feeding of 1-2-propanediol enhances growth of L. reuteri in 133 
vitro 134 
We developed an experimental system to study cross-feeding between L. reuteri 135 
and gut bacteria that produce 1,2-propanediol. We chose B. breve and E. coli which are 136 
known to produce 1,2-propanediol from fucose and rhamnose, respectively, which are 137 
substrates not utilized by L. reuteri. Since growth rates and growth conditions differ 138 
among L. reuteri, B. breve, and E. coli are, cross-feeding was not studied in co-culture. 139 
Instead, B. breve and E. coli were first grown under their respective optimal conditions 140 
and on the specific substrates that result in the production of 1,2-propanediol. Spent 141 
supernatant obtained from these fermentations was then supplemented with glucose 142 
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and half-strength mMRS (conditioned media; see Materials and Methods) and used for 143 
analyzing growth kinetics and metabolite production of L. reuteri strains (Table 1). 144 
Conditioned media from an isogenic mutant of B. breve with an insertion mutation in 145 
fucP (encoding the L-fucose transporter) that is unable to metabolize fucose into 1,2-146 
propanediol served as a control (Table 1).  147 
B. breve UCC2003 and its fucP mutant B. breve UCC2003-fucP were grown in a 148 
medium containing cellobiose with and without fucose. Fucose does not support the 149 
growth of B. breve UCC2003 yet is co-utilized with cellobiose to produce 1,2-150 
propanediol. Importantly, neither fucose or cellobiose are metabolized by L. reuteri (20). 151 
In the fucose/cellobiose-containing medium, B. breve UCC2003 and B. breve 152 
UCC2003-fucP reached similar cell density after 24 hours of growth (Fig. S2). L. reuteri 153 
PTA 6475 reached a significantly higher OD600 and showed elevated growth rate when 154 
grown in conditioned medium with supernatant of B. breve UCC2003 grown with fucose 155 
and cellobiose when compared to L. reuteri ΔpduCDE or L. reuteri PTA 6475 grown in 156 
conditioned medium of B. breve UCC2003 grown in the absence of fucose (Fig. 2A). 157 
The growth advantage of L. reuteri PTA 6475 was not observed in conditioned media 158 
from the B. breve UCC2003-fucP, even if grown in the presence of fucose (Fig. 2B). 159 
HPLC analysis confirmed the presence of 1,2-propanediol in the conditioned medium of 160 
B. breve UCC2003 but not B. breve UCC2003-fucP grown with fucose (Fig. S3A), and 161 
showed that enhanced growth of L. reuteri PTA 6475 was linked to the conversion of 162 
1,2-propanediol to propanol, which was not detected in L. reuteri ΔpduCDE cultures 163 
(Fig. 2C & D). Propionate, acetate, and ethanol could not be quantified as unknown 164 
compounds in the conditioned media interfered with the metabolite analysis. Fucose 165 
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and cellobiose did not alter the growth kinetics of the L. reuteri strains when grown in 166 
glucose (Fig. S4A), and they did not serve as growth substrates on their own (Fig. S4B), 167 
confirming that the enhanced growth in L. reuteri PTA 6475 was not due to a direct 168 
effect of residual concentrations of these sugars in the spend supernatant.  169 
1,2-propanediol results also from the fermentation of rhamnose by E. coli 170 
MG1655 (Fig S3B). Cross-feeding experiments revealed that L. reuteri PTA 6475 had a 171 
higher growth rate and reached a significantly higher cell density when grown in 172 
conditioned medium of E. coli grown on rhamnose when compared to L. reuteri 173 
ΔpduCDE, or L. reuteri PTA 6475 grown in conditioned medium from E. coli that did not 174 
contain rhamnose (Fig. 3A). Importantly, growth experiments of L. reuteri strains in 175 
media with rhamnose with or without glucose confirmed that rhamnose could neither be 176 
used as a carbon source nor alter growth (Fig. S4C & D). Metabolite analysis of 177 
fermentations conducted in the conditioned medium of E. coli grown on rhamnose 178 
revealed that L. reuteri PTA 6475, and not L. reuteri ΔpduCDE, could metabolize 1,2-179 
propanediol produced by E. coli and form propanol, propionate, and acetate (Fig. 3B-D; 180 
Fig. S5). Metabolite interference in the conditioned media did not allow the 181 
quantification of ethanol by HPLC.  182 
Together, these findings demonstrate that L. reuteri PTA 6475 utilizes 1,2-183 
propanediol produced by B. breve and E. coli from the fermentation of deoxyhexose 184 
sugars as an electron acceptor, enhancing its growth capabilities. 185 
 186 
Importance of 1,2-propanediol cross-feeding in the gastrointestinal tract 187 
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The ecological relevance of cross-feeding based on 1,2-propanediol in the 188 
gastrointestinal tract was investigated with a series of colonization experiments in 189 
gnotobiotic mice (Fig 4; Table S1 & S2). Germ-free Swiss-Webster mice (6-16 weeks 190 
old; male and female) were housed in individually ventilated cages (groups of 2-3). A 191 
fat-free diet was used in order to avoid possible confounding affects from the hydrolysis 192 
of dietary triglyceride fats, which is a source of glycerol (also utilized via the pdu cluster 193 
and enhances growth). Fecal cell numbers of colonizing strains were determined by 194 
selective plating (see Materials and Methods). 195 
As described earlier, B. breve produces 1,2-propanediol from fucose. Host 196 
mucins are an intrinsic source of fucose in the gastrointestinal tract, but B. breve does 197 
not possess glycosidases required for mucin degradation (9). 1,2-Propanediol cross-198 
feeding between B. breve and L. reuteri was therefore studied in triple-species 199 
associated mouse in the presence of the mucinolytic strain B. bifidum PRL2010, which 200 
is capable of degrading mucin and releasing fucose without producing 1,2-propanediol 201 
(Fig. 4A; Table S1) (9). We first tested wild-type and mutant L. reuteri strains separately. 202 
Mice were gavaged with an inoculum that contained B. bifidum PRL2010, B. breve 203 
UCC2003 or its fucP mutant, and either L. reuteri PTA 6475 or L. reuteri ΔpduCDE 204 
(Table S1, inocula A-D). In these experiments, the two Bifidobacterium strains formed 205 
stable populations of ~108-109 CFU/g (Fig. S6A-H), while the L. reuteri strains colonized 206 
at ~106-108 CFU/g (Fig. S7A). When colonizing with wild-type B. breve UCC2003, L. 207 
reuteri PTA 6475 formed higher populations than L. reuteri ΔpduCDE over the duration 208 
of the experiment. Contrary, fecal cell numbers of L. reuteri PTA6475 where 209 
consistently lower than L. reuteri ΔpduCDE when colonizing with B. breve UCC2003-210 
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fucP (but differences did not reach statistical significance due to the high variation 211 
between mice) (Fig. S7A). However, normalized ratios (see Materials and Methods) 212 
between fecal cell numbers of L. reuteri PTA 6475 and L. reuteri ΔpduCDE were 213 
significantly higher in mice colonized with B. breve UCC2003 as compared to mice 214 
colonized with B. breve UCC2003-fucP (Fig. 5A). Interestingly, while the ratio between 215 
L. reuteri PTA 6475 and L. reuteri ΔpduCDE was greater than 1 when the L. reuteri 216 
strains were co-colonized with B. breve UCC2003, it was substantially lower than 1 217 
when co-colonized with B. breve UCC2003-fucP (Fig. 5A). These finding suggests that 218 
the pdu cluster confers a fitness burden on L. reuteri unless 1,2-propanediol is provided, 219 
under which the cluster becomes advantageous. 220 
In a parallel set of experiments, we tested the importance of 1,2-propanediol 221 
cross-feeding in gnotobiotic mice that were gavaged with B. bifidum PRL2010, either B. 222 
breve UCC2003 or B. breve UCC2003-fucP, and both L. reuteri PTA 6475 and L. reuteri 223 
ΔpduCDE (wild-type and mutant) in direct competition (Table S1, inocula E & F). In 224 
agreement with the experiments with only one L. reuteri strain, Bifidobacterium species 225 
formed stable populations that were comparable among groups (~108-109 CFU/g; Fig. 226 
S6I-L). L. reuteri formed stable populations (~106-108 CFU/g), and concordant with the 227 
experiments using single strains of L. reuteri, cell counts of L. reuteri PTA 6475 were 228 
higher than the mutant  in mice colonized with B. breve UCC2003 as compared to the 229 
B. breve UCC2003-fucP (but differences were not statistically significant) (Fig. S7B). 230 
However, significant differences were observed between the relative proportions of the 231 
two L. reuteri strains. Specifically, L. reuteri PTA 6475 reached significantly higher 232 
proportions (>75 %) in mice colonized with B. breve UCC2003 as compared to B. breve 233 
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UCC2003-fucP (Fig. 5B). Interestingly, L. reuteri ΔpduCDE reached ~75 % of the total 234 
Lactobacillus population in mice colonized with B. breve UCC2003-fucP (Fig. 5B), 235 
supporting the notion that the pdu cluster is a fitness burden to L. reuteri unless 1,2-236 
propanediol is provided. Overall, these observations demonstrated that B. breve 237 
UCC2003 can provide 1,2-propanediol as the result of a trophic chain from the 238 
degradation of mucin by B. bifidum PRL2010 that facilitates colonization of L. reuteri in 239 
the gastrointestinal tract (9).  240 
A set of dual-associated gnotobiotic mouse experiments were also conducted to 241 
test if the production of 1,2-propanediol, from the metabolism of rhamnose by E. coli, 242 
influences the fitness of L. reuteri in the gastrointestinal tract. Mice were colonized 243 
either with E. coli and L. reuteri PTA 6475 and L. reuteri ΔpduCDE alone or in 244 
competition. Rhamnose was provided to mice in the drinking water (Fig. 4B; Table S2). 245 
Stable populations of E. coli were reached in all mice (~109 CFU/g), and the provision of 246 
rhamnose led to an ~10-fold increase in fecal cell numbers of E. coli (Fig. S8). Contrary 247 
to the findings with gnotobiotic mice colonized by bifidobacteria, L. reuteri ΔpduCDE 248 
colonized with higher cell numbers and outcompeted L. reuteri PTA 6475 under all 249 
conditions tested (Fig. 5C & D). This was indicated by ratios of less than 1 between L. 250 
reuteri PTA 6475 and L. reuteri ΔpduCDE in mice colonized with single L. reuteri strains 251 
(Fig. 5C) and an enrichment of the mutant to ~60 % of the total Lactobacillus population 252 
in competition experiments (Fig. 5D). The latter results resample those obtained with 253 
the triple-species Bifidobacterium experiments in mice colonized with B. breve 254 
UCC2003-fucP (Fig. 5), confirming the fitness burden of the pdu cluster.    255 
 256 
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Cross-feeding between members of the gut microbiota based on 1,2-propanediol is 258 
considered an important ecological process that shapes the gut microbiome and its 259 
metabolism. However, conclusions have so far been derived from in vitro experiments 260 
and metagenomic predictions. In this study, we demonstrate that L. reuteri engages in 261 
trophic interactions with bacteria that are common in the human gut and provide 1,2-262 
propanediol, which is used predominantly to regenerate reduced metabolic cofactors. 263 
Using isogenic mutants in both the bacterium that produces 1,2-propanediol and L. 264 
reuteri, we ensured that this cross-feeding interaction is in fact based on this metabolic 265 
intermediate. We further established that the pduCDE genes constitute a fitness burden 266 
for L. reuteri in the gut unless 1,2-propanediol is provided, which makes the cluster 267 
ecologically advantageous. Our findings therefore provide insight into both the 268 
ecological role of the pdu cluster in L. reuteri and how it evolved.   269 
Our results demonstrate that in vitro, L. reuteri can obtain a growth advantage by 270 
cross-feeding from 1,2-propanediol derived from the fermentation of fucose and 271 
rhamnose by B. breve and E. coli, respectively. These findings extend previous work 272 
showing that pdu cluster-containing L. reuteri strains grow at a faster rate and to a 273 
higher cell yield in the presence of glycerol or 1,2-propanediol (19). Contrary to findings 274 
with L. reuteri DSM 20016, which produces propanol and propionate in equimolar 275 
concentrations through disproportionation when utilizing 1,2-propanendiol as a sole 276 
substrate (22), L. reuteri PTA 6475 produces propanol in excess over propionate 277 
(Figure 1B) and enhances acetate formation (Fig. 1D) when utilizing 1,2-propanendiol 278 
together with glucose. These metabolic patterns suggest that when L. reuteri PTA 6475 279 
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grows with glucose, 1,2-propanediol functions mainly as an electron acceptor, allowing 280 
the conversion of acetyl-phosphate to acetate and to generate an extra ATP (30). Apart 281 
from enhancing bacterial growth, 1,2-propanendiol metabolism by L. reuteri can 282 
therefore contribute to SCFA formation in the gut, which might have health implications 283 
as propionate and acetate impact host physiology, e.g. by contributing to 284 
gluconeogenesis in the liver, reducing cholesterol, and promoting satiety (5, 18). 285 
Our experiments in gnotobiotic mice provide empirical evidence for the ecological 286 
relevance of 1,2-propanendiol cross-feeding for the ecological performance of a gut 287 
symbiont in the gastrointestinal tract. The use of the respective pduCDE and fucP 288 
mutants of L. reuteri and B. breve in the mouse experiments indicated that this trophic 289 
interaction was specifically based on 1,2-propanediol produced through the 290 
fermentation of fucose. Since B. breve cannot degrade mucins, and the mouse feed 291 
was devoid of fucose, the findings suggests that L. reuteri benefits from 1,2-propanediol 292 
resulting from interspecies trophic interactions between bifidobacteria, in which B. 293 
bifidum PRL2010 degrades host mucin and provides fucose for B. breve to produce 1,2-294 
propanediol (9). The hydrolysis of mucin is suggested to play a key role in the facilitation 295 
of bacterial species in the gut microbiota and have been demonstrated in vitro (7, 31, 296 
32) and with bacterial pathogens in vivo (e.g. Salmonella spp. and Clostridium difficile) 297 
(23, 33). Our data suggests that it also plays a role in cross-feeding interactions among 298 
symbionts or commensals, ultimately conferring a fitness advantage to L. reuteri in the 299 
murine gut through the provision of 1,2-propanendiol.  300 
Although our experiments demonstrated 1,2-propanediol cross-feeding between 301 
bifidobacteria and L. reuteri, equivalent findings were not observed in mouse 302 
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experiments with L. reuteri and E. coli. This observation can potentially be attributed to 303 
a phenomenon called carbon catabolite repression or the “all-or-none” effect in E. coli, 304 
in which a hierarchy-based regulatory system controls the sequential uptake of carbon 305 
sources (34). The mouse diet was highly saturated with glucose (34.4 % w/w) and, in 306 
vitro, the presence of glucose suppresses the uptake of other carbohydrates in E. coli 307 
(35), which is in agreement with our finding that E. coli MG1655 did not produce 1,2-308 
propanendiol from rhamnose while in the presence of glucose (Fig. S3B). Hence, it is 309 
possible that the uptake and metabolism of rhamnose into 1,2-propanediol by E. coli 310 
was suppressed in the murine gut.  311 
Interestingly, the mouse experiments consistently revealed a fitness burden of 312 
the pduCDE genes when 1,2-propendiol was absent. Fitness trade-offs are well 313 
understood in the evolution of antibiotic resistance in bacteria, where resistance genes 314 
are costly and lead to a reduction of growth (36), and are therefore often lost in the 315 
absence of antibiotic pressure (37). Our findings indicate that genes that facilitate cross-316 
feeding interactions are also subjected to fitness trade-offs in that they are only 317 
beneficial when the metabolite is provided. Such trade-offs have also been shown in 318 
cross-feeding based on the exchange of carbohydrates. Bacteroides ovatus possesses 319 
an enzyme system dedicated to the digestion of polysaccharides that does not directly 320 
benefit itself, but rather cooperative members of the gut microbiota through reciprocal 321 
cross-feeding. This enzyme system is energetically unfavorable and in the absence of a 322 
reciprocating species, a knock-out mutant strain can outcompete the enzyme-encoding 323 
wild-type (38). In L. reuteri, the fitness burden of the pdu genes provides a possible 324 
explanation for the evolution of the pdu cluster (26). Although likely ancestral to 325 
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currently known lineages of L. reuteri, there is evidence of a deletion of the pdu cluster 326 
from most rodent strains (25, 26). Growth substrates are abundant in the forestomach 327 
and bacteria providing 1,2-propanediol are absent (25, 26), which might have led to loss 328 
of the pdu cluster as it was evolutionary advantageous, in agreement with the Black 329 
Queen Hypothesis (39). In the human distal gut, 1,2-propanediol is likely provided 330 
through other microbiota members, which may explain why the pdu cluster is conserved 331 
among these strains (26, 27).  332 
Although cross-feeding based on 1,2-propandiol is only one of many trophic 333 
interactions that establish interactive networks within the gut microbiota, this study 334 
provides important information as it establishes the importance and consequences of 335 
cross-feeding for the ecological performance of the involved members. Such knowledge 336 
has repercussions for our understanding on the ecological and evolutionary forces that 337 
shape gut ecosystems and determine how they function (38, 40-42). In addition, an 338 
understanding of mutualistic interactions has important implications as it can be 339 
translated into improved microbial-based strategies to modulate gut microbiomes (i.e. 340 
probiotics). A challenge encountered in the field of probiotics is that gut ecosystems are 341 
homeostatic, resilient to change, and thus difficult to modulate, and most probiotics do 342 
not persist or change the resident community (43-46). One solution to this problem is 343 
the adoption of an ecological framework for probiotic applications (44). A consideration 344 
of the mutualistic and facilitative interactions between community members can be used 345 
for designing probiotic strain mixtures or personalized probiotic applications with the 346 
goal to achieve a more successful long-term persistence, which might be beneficial for 347 
certain applications. For example, 1,2-propanediol cross-feeding could be considered in 348 
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generating probiotic products by pairing L. reuteri with Bifidobacterium species that 349 
release fucose from the degradation of host-derived substrates and convert it into 1,2-350 
propanediol (9, 12). Additionally, bifidobacteria are more prevalent in the infant gut (47, 351 
48) and some strains only partly utilize HMOs, releasing fucose, possibly forming an 352 
effective synergistic combination with L. reuteri (3, 32, 40). Furthermore, cross-feeding 353 
of 1,2-propanediol derived from gut symbionts and S. enterica serovar Typhimurium has 354 
been demonstrated to play a role in promoting pathogen expansion in the gut (23). L. 355 
reuteri could play a therapeutic role in excluding pathogenic Salmonella during 356 
gastroenteritis, by directly competing for the intermediary metabolite. Overall, this 357 
information could not only be used to formulate probiotic mixtures and synbiotic 358 
products, but potentially personalize probiotic applications based on the baseline 359 
microbiome (43).  360 
 361 
Materials and Methods 362 
Bacterial strains and culture conditions 363 
Bacterial strains used in this study are listed in Table 2. L. reuteri strains were grown 364 
in de Man, Rogosa, and Sharpe (MRS) medium (Difco) in an anaerobic chamber (gas 365 
mix of 5 % CO2, 5 % H2, and 90 % N2). B. bifidum PRL2010, B. breve UCC2003, and B. 366 
breve UCC2003-fucP were grown anaerobically in MRS medium supplemented with 367 
0.05 % L-cysteine. E. coli were grown in Luria-Bertani (LB) broth with agitation. All 368 
incubations were performed at 37 °C. 369 
Evaluation of the impact of 1,2-propanediol on L. reuteri ATCC PTA 6475 growth 370 
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Overnight cultures of L. reuteri PTA 6475 and L. reuteri ΔpduCDE were inoculated at 371 
1 % into 15 ml of half-strength mMRS (49) containing 25mM glucose alone, 50 mM of 372 
1,2-propanediol (Sigma-Aldrich) alone, or 25mM glucose plus 50mM of 1,2-propanediol. 373 
Growth of cell cultures were monitored based on OD600 with a spectrophotometer every 374 
3 h over the span of 12 h. One mL samples were collected for HPLC analysis every 3 h. 375 
All experiments were performed in triplicate at 37 °C under anaerobic conditions.  376 
In vitro production of 1,2-propanediol and cross-feeding assay development 377 
Pre-cultures of B. breve strains and E. coli were prepared as follows. Full-strength 378 
mMRS supplemented with 30 mM cellobiose ± 30 mM L-fucose were inoculated with 1 379 
% of overnight cultures of B. breve UCC2003 or B. breve UCC2003-fucP. Full-strength 380 
mMRS containing 25 mM of glucose or 30 mM of L-rhamnose were inoculated with 1 % 381 
of overnight E. coli MG1655 cultures. These fermentations were conducted under 382 
anaerobic conditions for 24 h at 37 °C. Conditioned media were prepared from pre-383 
cultures as follows. Cells were removed from pre-cultures by centrifugation (5000 x g for 384 
10 minutes) after which the supernatant was collected. The supernatant was 385 
supplemented with half-strength mMRS from scratch (50 % w/v; mMRS dry reagents) 386 
and glucose (25 mM; dry reagent) to the supernatant. These were further adjusted to 387 
pH 6.6 and filter sterilized (0.22 µm), stored at 4 °C and used within 48 h. Conditioned 388 
media are described in Table 1. For growth experiments, conditioned media were 389 
inoculated with L. reuteri strains (1 % inoculation). Growth was monitored for 12 h by 390 
measuring OD600 with a spectrophotometer and 1 mL samples for HPLC analysis were 391 
collected every 3 h. All experiments were performed in triplicate under anaerobic 392 
conditions at 37 °C.  393 
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Experiments in gnotobiotic mice  394 
 All animal experiments were performed with the approval of the Animal Care and 395 
Use Committee (ACUC) of the University of Alberta (AUP 00002764). Germ-free Swiss-396 
Webster mice (6-16 weeks of age, male and female) were bred and maintained in the 397 
Health Sciences Laboratory Animals Services (HSLAS) Facility at the University of 398 
Alberta. Mice were randomly selected and moved from a flexible-film isolator and 399 
housed in sterile, individually ventilated, positive-pressured biocontainment cages for 400 
the duration of the experiments (IsoCage P Biocontainment; Tecniplast). To avoid 401 
possible confounding effects of glycerol, which is also utilized by the pdu cluster-402 
encoded diol/glycerol dehydratase (50) , an irradiated fat-free diet (34.4 % glucose and 403 
34.4 % cornstarch; Teklad TD.180765) was used in order to minimize possible 404 
interference from the hydrolysis of triglyceride fats. After transfer to the biocontainment 405 
cages, mice were fed with the new diet for 3 d before colonization with the bacteria.  406 
To study the cross-feeding of 1,2-propanediol in the gastrointestinal tract, groups of 407 
mice (n=5), 2 to 3 mice per cage, were assigned to receive either Bifidobacterium-L. 408 
reuteri triple-species mixtures (Table S1) or E. coli-L. reuteri double-species mixtures 409 
(Table S2). To test for cross-feeding of 1,2-propanediol produced from mucin derived 410 
fucose, mice were gavaged with Bifidobacterium-L. reuteri triple-species mixtures 411 
containing B. bifidum PRL2010, either B. breve UCC2003 or B. breve UCC2003-fucP, 412 
and either L. reuteri PTA 6475 or L. reuteri ΔpduCDE (single L. reuteri strains), or both 413 
strains in competition (Table S1). To test for cross-feeding of dietary rhamnose, we 414 
gavaged mice with E. coli-L. reuteri double-species mixtures containing E. coli and L. 415 
reuteri PTA 6475 or L. reuteri ΔpduCDE (single L. reuteri strains), or both strains in 416 
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competition (Table S2). Rhamnose was provided in the drinking water (2 % w/v). Each 417 
mouse was gavaged with 200 µL of the corresponding bacterial cell mixtures containing 418 
~108 viable cells of each strain. Fecal pellets were collected from individual mice 1, 3, 5, 419 
and 7 days after inoculation and plated. Selective plating was used to enumerate 420 
bacterial cells in fecal samples as follows: Modified Rogosa agar plates were used to 421 
quantify L. reuteri strains (51). L. reuteri PTA 6475 and L. reuteri ΔpduCDE were 422 
differentiated using a reuterin hydrazone detection assay (52). MacConkey agar was 423 
used for quantifying E. coli. Bifidobacterium were selected using Bifidobacterium 424 
selective iodoacetate mupirocin (BSIM) agar as previously described (48). B. bifidum 425 
PRL2010 and B. breve strains were differentiated based on colony morphology.    426 
Metabolite analysis of post-fermentation 427 
1,2-Propanediol, propanol, propionate, acetate, and ethanol were measured using 428 
HPLC. A BioRad Aminex HPX-87H column (300 mm x 7.8 mm) and a refractive index 429 
detector was used (HPLC-RI). Samples taken from fermentations were mixed with 70 % 430 
HClO4 (0.005 % v/v), stored at 4 °C overnight to precipitate proteins, centrifuged (18,800 431 
x g for 5 minutes), filtered (0.22 µm), and stored at -20 °C before injection into HPLC. 432 
Ten µL were injected and eluted with 5 mM H2SO4 at a flow rate of 0.4 ml/min at 70 °C. 433 
1,2-Propanediol, propanol, propionate, acetate, and ethanol were quantified using 434 
external standards. 435 
Statistical analysis 436 
Statistical significance between L. reuteri growth curves were determined by two-437 
way analysis of variance (ANOVA) with Bonferroni multiple comparisons test (α = 0.05). 438 
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An unpaired two-tailed Student’s t-test was used to analyze significance between B. 439 
breve growth in mMRS supplemented with cellobiose ± fucose. 440 
Comparisons between L. reuteri PTA 6475 and L. reuteri ΔpduCDE CFU recovered 441 
from fecal samples over the duration of the gnotobiotic mice experiments were 442 
performed by unpaired two-tailed Student’s t-test. Tests were conducted between L. 443 
reuteri strains that were associated with (i) B. breve UCC2003 or (ii) B. breve UCC2003-444 
fucPin the triple-species experiments and E. coli-L. reuteri double-species experiments 445 
with rhamnose (iii) present or (iv) absent. 446 
For the gnotobiotic mice experiments inoculated with the ‘single L. reuteri strain’ 447 
mixtures (Table S1 & 2), CFU of L. reuteri PTA 6475 and L. reuteri ΔpduCDE recovered 448 
from mouse feces were used to produce normalized ratios. Ratios were generated 449 
using the formula (equation 1) below, where 𝑎𝑛 is a CFU value for L. reuteri PTA 6475 - 450 
from a single mouse - used in the comparison, 𝑏𝑛  is the CFU value of L. reuteri 451 
ΔpduCDE from each mouse in the group, and 𝑛𝑏  is the total population of mice 452 









The formula was used to generate sets of ratios for the following comparisons from 455 
the ‘Single L. reuteri strain’ mice experiments: (i) B. breve UCC2003 vs B. breve 456 
UCC2003-fucP and (ii) E. coli-L. reuteri double-associated mice in the presence vs the 457 
 on A



















absence of rhamnose. Statistical significance between the sets of ratios were 458 
determined by Mann-Whitney U test (P value < 0.05).   459 
Fisher’s exact test was used to determine statistical significance between L. reuteri 460 
population frequencies from murine groups inoculated with ‘L. reuteri strains in 461 
competition’ mixtures (P value < 0.05). This was performed between groups of mice 462 
from either: (i) Bifidobacterium-L. reuteri triple-species associations including B. breve 463 
UCC2003 vs B. breve UCC2003-fucP(ii) E. coli-L. reuteri double-species associations 464 
with murine diet supplemented with rhamnose vs without rhamnose. Statistical analyses 465 
were performed using GraphPad Prism 6.07. 466 
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N/a 30 mM Cellobiose BM (C) Control for L. reuteri growth 
absent of 1,2-propanediol 
production 
 
 30 mM Fucose 30 mM Cellobiose BM (CF) For the study of effect of 
1,2-propanediol produced 
from Fucose fermentation 





N/a 30 mM Cellobiose B-fucP M (C) Control for L. reuteri growth 
absent of 1,2-propanediol 
production 
 
 30 mM Fucose 30 mM Cellobiose B-fucP M (CF) Control for L. reuteri growth 




N/a 25 mM Glucose EM (G) Control for L. reuteri growth 
absent of 1,2-propanediol 
production 
 
 30 mM 
Rhamnose 
N/a EM (R) For the study of effect of 
1,2-propanediol produced 
from Rhamnose 
fermentation on L. reuteri 
N/a: not applicable 495 
496 
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 498 
Table 2. Strains used in this study  499 
Species (strain code) Origin Relevant features Reference 
Lactobacillus reuteri    
ATCC PTA 6475 
 
L. reuteri ΔpduCDE 
Breast Milk 
 
Isogenic mutant of 
PTA 6475  
1,2-propanediol utilizer with 
complete pdu cluster 






Escherichia coli    
MG1655 Lab-derived strain L-rhamnose utilizer, 1,2-
propanediol producer 
The Coli Genetic 
Stock Center 
(CGSC) 
Bifidobacterium bifidum    
PRL2010 Infant stool Mucin degrader, L-fucose 
producer 
(32) 











Insertion mutant of the L-
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Figures legends 502 
Figure 1. Impact of 1,2-propanediol on growth and metabolism of L. reuteri PTA 6475 503 
and L. reuteri ΔpduCDE. (A) L. reuteri strains were grown in half-strength mMRS 504 
supplemented with either glucose (Glc; 25 mM), 1,2-propanediol (50 mM), or a mixture 505 
of the two. Asterisks indicate a significant difference (Two-way ANOVA; p < 0.001) in 506 
growth of L. reuteri PTA 6475 on glucose plus 1,2-propanediol compared to the other 507 
conditions. (B-C) Utilization of 1,2-propanediol and production of propanol and 508 
propionate by (B) L. reuteri PTA 6475 and (C) L. reuteri ΔpduCDE during growth on 509 
glucose in the presence of 1,2-propanediol. (D-E) Production of (D) acetate and (E) 510 
ethanol by the two strains during growth on glucose in the presence of 1,2-propanediol.  511 
 512 
Figure 2. Growth and metabolites of L. reuteri PTA 6475 and L. reuteri ΔpduCDE in 513 
conditioned media of B. breve UCC2003 and B. breve UCC2003-fucPgrown with 514 
cellobiose alone or with the addition of fucose. Growth curves of (A) L. reuteri strains in 515 
B. breve UCC2003 conditioned media and (B) L. reuteri in B. breve UCC2003-fucP 516 
conditioned media. Asterisks indicate a significant difference (Two-way ANOVA; p < 517 
0.001) in growth of L. reuteri PTA 6475 grown in B. breve UCC2003 conditioned 518 
medium that had fermented cellobiose and fucose together compared to growth of L. 519 
reuteri PTA 6475 in B. breve UCC2003 conditioned medium without fucose or to L. 520 
reuteri ΔpduCDE grown in all conditioned media derived from B. breve UCC2003. (C-D) 521 
Utilization of B. breve derived 1,2-propanediol present in the conditioned media and 522 
production of propanol in cultures of (C) L. reuteri PTA 6475 and (D) L. reuteri 523 
ΔpduCDE grown in the conditioned medium of B. breve UCC2003 grown in the 524 
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presence of fucose. Propionate, acetate, and ethanol concentrations could not be 525 
determined due to interference of unknown compounds in the medium. Abbreviations: 526 
BM, B. breve UCC2003 conditioned media; B-fucP M, B. breve UCC2003-fucP 527 
conditioned media; (C), pre-culture fermentations of cellobiose only; (CF), pre-culture 528 
fermentations of cellobiose with added fucose (See Table 1 for more details about 529 
media used in the study).  530 
 531 
Figure 3. Growth curves and metabolites of L. reuteri PTA 6475 and L. reuteri 532 
ΔpduCDE in conditioned media of E. coli grown with glucose or rhamnose. (A) Growth 533 
of L. reuteri strains. Asterisks indicate a significant difference (Two-way ANOVA; p < 534 
0.01) in growth of L. reuteri PTA 6475 grown in E. coli conditioned medium that had 535 
fermented rhamnose compared to E. coli conditioned medium that fermented glucose 536 
and to growth of L. reuteri ΔpduCDE in both E. coli conditioned media fermentations of 537 
either glucose or rhamnose. (B-C) Utilization of E. coli-derived 1,2-propanediol, and 538 
production of propanol and propionate by (B) L. reuteri PTA 6475 and (C) L. reuteri 539 
ΔpduCDE grown in conditioned medium from E. coli grown with rhamnose. (D) 540 
Comparison of acetate production by the two strains grown in conditioned medium from 541 
E. coli grown with rhamnose. Ethanol concentrations could not be determined due to 542 
interference of an unknown compound in the medium. Abbreviations: EM, E. coli 543 
conditioned media; (G), pre-culture fermentation of glucose only by E. coli; (R), pre-544 
culture fermentation of rhamnose only by E. coli. (See Table 1 for more details about 545 
media used in the study).  546 
 547 
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Figure 4.  Graphical illustration of hypothesized trophic interactions of 1,2-propanediol 548 
in gnotobiotic mice. (A) In triple-species associated gnotobiotic mice (colonized by B. 549 
bifidum, B. breve, and L. reuteri), B. bifidum liberates fucose from the degradation of 550 
host mucin, which is metabolized by B. breve UCC2003 producing 1,2-propanediol, that 551 
is subsequently utilized by L. reuteri PTA 6475. (B) In dual-species (E. coli and L. 552 
reuteri) associated mice whose diet has been supplemented with rhamnose added 553 
through the drinking water, E. coli metabolizes rhamnose producing 1,2-propanediol 554 
that is subsequently utilized by L. reuteri PTA 6475.  555 
 556 
Figure 5. Populations of L. reuteri PTA 6475 and L. reuteri ΔpduCDE in the 557 
gastrointestinal tract of triple-species and double-species associated gnotobiotic mice. 558 
(A) Normalized ratios between L. reuteri PTA 6475 to L. reuteri ΔpduCDE obtained from 559 
Bifidobacterium-L. reuteri triple-species associated gnotobiotic mice in which 560 
colonization by L. reuteri PTA 6475 and L. reuteri ΔpduCDE was tested separately. “+” 561 
indicates mice colonized with B. breve UCC2003 and “-” indicates mice colonized with 562 
B. breve UCC2003-fucP. (B) Percent CFU for L. reuteri PTA 6475 and L. reuteri 563 
ΔpduCDE as measured in triple-species associated gnotobiotic mice in which the two L. 564 
reuteri strains were tested in competition. (C) Normalized ratios between L. reuteri PTA 565 
6475 and L. reuteri ΔpduCDE in E. coli-L. reuteri double-species associated gnotobiotic 566 
mice in which colonization of L. reuteri PTA 6475 and L. reuteri ΔpduCDE was tested 567 
separately. (D) Percent CFU for L. reuteri PTA 6475 and L. reuteri ΔpduCDE mutant in 568 
double-species associated gnotobiotic mice in which the two L. reuteri strains were 569 
tested in competition. “+” indicates the presence of rhamnose (Rha) in the diet, while “-” 570 
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indicates absence of rhamnose in the diet. Statistical significance for ratios and percent 571 
abundance (% CFU) was determined using Mann-Whitney test and Fisher’s exact test, 572 
respectively. 573 
 574 
Table S1. Strains used in experiments with Bifidobacterium-L. reuteri triple-species 575 
associated gnotobiotic mice. 576 
 577 
Table S2. Strains used in experiments with E. coli-L. reuteri double-species associated 578 
mice. 579 
   580 
Figure S1.  Concentrations of (A) acetate and (B) ethanol in media after growth of L. 581 
reuteri PTA 6475 and L. reuteri ΔpduCDE on glucose (Glc) in the presence or absence 582 
of 1,2-propanediol.  583 
 584 
Figure S2. Growth of B. breve UCC2003 and B. breve UCC2003-fucP in mMRS 585 
supplemented with cellobiose (30 mM; Cell), fucose (30 mM; Fuc), cellobiose and 586 
fucose, or with no carbon source (No Carb) after 24 hours. 587 
 588 
Figure S3. Total 1,2-propanediol concentrations in media after growth with (A) B. breve 589 
UCC2003 and B. breve UCC2003-fucP after fermentation of cellobiose (Cell) and 590 
cellobiose plus fucose (Cell + Fuc). (B) 1,2-propenediol concentrations in E. coli cultures 591 
after growth with glucose (Glc), rhamnose (Rha), or glucose and rhamnose (Glc + Rha).  592 
 593 
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Figure S4. Growth of L. reuteri PTA 6475 and L. reuteri ΔpduCDE in the presence of 594 
deoxyhexose sugars. L. reuteri strains do not utilize (A & B) cellobiose (Cell), fucose 595 
(Fuc), or (C & D) rhamnose (Rha) as growth substrates or electron acceptors when 596 
cultured with glucose (Glc). 597 
 598 
Figure S5. Acetate production of L. reuteri PTA 6475 and L. reuteri ΔpduCDE in the 599 
conditioned media of E. coli fermentation of glucose and rhamnose. In the symbol 600 
labels, E. coli conditioned media is abbreviated as EM, followed by fermentation of 601 
glucose by E. coli as indicated with (G), and rhamnose with (R) (See Table 1 for more 602 
details about media used in the study). 603 
 604 
Figure S6.  Quantification of Bifidobacterium strains in fecal samples from triple-species 605 
associated gnotobiotic mice. Fecal CFU of B. bifidum PRL2010 recovered from of 606 
gnotobiotic mice inoculated with (A) B. breve UCC2003 and L. reuteri PTA 6475 or (B) 607 
B. breve UCC2003 and L. reuteri ΔpduCDE. Fecal CFU of B. bifidum PRL2010 from 608 
gnotobiotic mice inoculated with (C) B. breve UCC2003-fucP and L. reuteri PTA 6475 or 609 
(D) B. breve UCC2003-fucP and L. reuteri ΔpduCDE. Fecal CFU of B. breve UCC2003 610 
from gnotobiotic mice inoculated with (E) B. bifidum PRL2010 and L. reuteri PTA 6475 611 
or (F) B. bifidum PRL2010 and L. reuteri ΔpduCDE. Fecal CFU of B. breve UCC2003-612 
fucP from gnotobiotic mice inoculated with (G) B. bifidum PRL2010 and L. reuteri PTA 613 
6475 or (H) B. bifidum PRL2010 and L. reuteri ΔpduCDE. Fecal CFU of B. 614 
bifidum PRL2010 from gnotobiotic mice inoculated with L. reuteri PTA 6475 and L. 615 
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reuteri ΔpduCDE in competition as well as with (I) B. breve UCC2003 or (J) B. 616 
breve UCC2003-fucP. (K) Fecal CFU of B. breve UCC2003 from gnotobiotic mice 617 
inoculated with B. bifidum PRL2010 and L. reuteri PTA 6475 and L. reuteri ΔpduCDE in 618 
competition. (L) Fecal CFU of B. breve UCC2003-fucP from gnotobiotic mice inoculated 619 
with B. bifidum PRL2010 and L. reuteri PTA 6475 and L. reuteri ΔpduCDE in 620 
competition. 621 
Figure S7. Quantification of L. reuteri strains from triple-species and double-species 622 
associated gnotobiotic mice experiments. (A-B) CFU of L. reuteri recovered from feces 623 
of the Bifidobacterium triple-species gnotobiotic mice experiments containing either (A) 624 
single L. reuteri strains or (B) L. reuteri strains in competition. “+” indicates mice 625 
colonized with B. breve UCC2003 and “-” indicates mice colonized with the fucP mutant 626 
of B. breve UCC2003. (C-D) CFU of L. reuteri recovered from feces of E. coli double-627 
species gnotobiotic mice experiments from either (C) single L. reuteri strains or (D) L. 628 
reuteri strains in competition. “+” indicates the presence of rhamnose (Rha) in the diet, 629 
while “-” indicates absence of rhamnose in the diet. 630 
 631 
Figure S8. Quantification of E. coli from double-species associated gnotobiotic mice 632 
experiments. CFU of E. coli recovered from ‘single L. reuteri strain’ bacterial mixtures in 633 
the (A) presence of rhamnose in the diet, (B) absence of rhamnose in the diet, and from 634 
(C) L. reuteri in competition where rhamnose was either supplemented into the mouse 635 
diet or not.  636 
 637 
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